Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Catheter Type, Indication & Application The global intravascular temperature management market will witness a robust CAGR of 4.14%, valued at $279.23 million in 2021, expected to appreciate and reach $402.42 million by 2030, confirms Strategic Market Research. Market Drivers - Increase in Cardiovascular Diseases, Surgical Procedures, and a Rise of Awareness for the Usage of the Intravascular Temperature Devices The continuous rise in the prevalence of cardiovascular diseases is one of the main factors propelling this market's overall growth during the forecasted period. According to WHO, cardiovascular diseases (CVDs) are one of the leading causes of mortalities globally, costing approximately 17.9 Mn lives each year. More than 4 out of 5 CVD mortalities are caused due to heart attacks & strokes, and 1/3 rd. of these deaths occur prematurely in people below 70 years of age. Apart from this, the rise in demand for the intravascular cooling device, temperature management solutions, Zoll cooling catheter, Zoll proteus, thermoguard ICU, etc., are facilitating the overall market growth significantly within the stipulated time frame of 2020-2030. Furthermore, the continuous increase in the total number of surgical procedures across the globe and the rising awareness of intravascular temperature management worldwide is significantly contributing to the prosperity of the intravascular temperature management market. According to the National Library of Medicine and the National Institute of Health, a staggering 310 Mn major surgeries are performed each year across the globe; nearly 40 to 50 Mn in the USA and almost 20 Mn in Europe. It is expected that (1–4) % of these patients are most likely to die, up to 15% can have serious cases of postoperative morbidities, and nearly 5–15% will be readmitted to the hospital within 30 days. Restraints - A Much Higher Price and too Much Labour Intensiveness Resulting in the Generation of Temperatures Under the Required Threshold Standard The higher costs of these devices are severely hindering the growth of the global intravascular temperature management market to a great extent. Moreover, the disadvantage of using the intravascular methods is that they are very much labour-intensive, which often results in lower temperatures than the target temperature & are also not effective in maintaining the target temperature on par as required. Opportunities - Rise of Government Funding for Further Development in the Technology of the Intravascular Devices Due to the continuous increase in demand for intravascular devices across the globe, the worldwide governments at present are sheer focusing on the rapid technological advancements of these devices by investing a hefty amount of money which in turn will provide huge opportunities for the market’s prosperity in the future. Market Analysis Of Different Segments Covered in the Report Based on Type: Intravascular Cooling Catheter Intravascular Warming Catheter Based on Product Consumables Systems Based on Indication: Acute myocardial infarction (AMI) Stroke TBI (Traumatic Brain Injury) Cardiac Arrest Fever/Infection Other Based on Applications: Operative Care Acute/Critical Care Preoperative Care Post-operative Care Based on End-User: Surgical Centers Emergency Care Units Ambulatory Surgical Centers Other Regional Coverage Analysis North America US Canada Mexico Rest of North America Europe France U.K Netherlands Switzerland Germany Finland Belgium Russia Italy Spain Turkey Rest of Europe Asia Pacific China Japan India South Korea Malaysia Australia Singapore Thailand Indonesia Philippines Rest of Asia-Pacific LAMEA Brazil Argentina Uruguay Saudi Arabia Rest of LAMEA Segments Analysis & Insights Based on Type, the “Intravascular Warming Catheter” segment held the highest share of nearly 63.22 % of the entire market in 2020. Intravascular warming keeps the temperatures of critically ill patients normal. Induced hypothermia is a kind of Intravascular Warming that has gained immense popularity across the globe as it is a cost-effective strategy for neurological protection during major vascular surgeries or for the situations where critical neurological surgeries are needed to be performed, which in turn augments the overall growth of this segment. Based on Product, the “Consumables” segment comprehensively held the maximum share of around 76.15% of the entire market in 2020. A continuous increase of awareness of the more and more usage of consumables and their high rise in demand across the world is driving the overall market growth of this segment efficiently. Based on Indication, the “Cardiac Arrest” segment held the maximum market share of nearly 67.23%, along with a steady CAGR in 2020. Severe traumatic brain Injury after CPR (cardiopulmonary resuscitation) has been known to be the most common reason for mortality of cardiac arrest (OHCA) patients. Hence, to detect the CPR symptoms at an early stage, the demand for intravascular temperature devices is rising extensively, which in turn is propelling the overall growth of this segment. Based on Applications, the “Acute/Critical Care” segment accounted for the highest share of approximately 42.17% of the entire market in 2020. Acute/Critical care adequately caters to patients with life-threatening or severe injuries and illnesses that require close supervision and constant care from life support equipment & medication to ensure normal body functions. All of these pivotal factors are facilitating the overall growth of this segment. According to WHO, approximately 5.8 crore people die because of cardiac arrests in the world per year. Based on End-User, the “Surgical Centers” segment dominated the market in all aspects in 2020. Most of the patients prefer to go to the Surgical Centers for immediate temperature management to detect early cardiac arrest symptoms, which in turn is driving the growth of this segment extensively. Based on Region, “North America” held the highest share of the market with a decent CAGR value throughout the stipulated time period of 2020-2030, followed by Europe. Factors such as the high incidence of cardiac arrests and neurological disorders, the increasing number of surgical centres, & the higher rate of adoption of technologically advanced devices in North American countries are driving the overall growth of the market significantly in the region. Global Intravascular Temperature Management Market Competitive Landscape Analysis Competitive Landscape Analysis is one of the genuine methods to figure out the key competitors that are prevailing in the global market environment. The comparison is performed based on the total amount of revenue generated, the company overview, global presence, company strengths and flaws, production capacities, investments in the field of Research & Development, market potential, production sites and facilities, and company financials etc. The list of key players that are incorporated in the Global Intravascular Temperature Management Market report are: 3M company Smiths Group Plc ZOLL Medical The 37Company Belmont Instrument Biegler Stihler Electronic GmbH BD company Geratherm Medical AG Stryker Corporation The Surgical Company BV VYAIRE MEDICAL INC Intravascular Temperature Management Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 Market size value in 2021 USD 279.23 Million Revenue forecast in 2030 USD 402.42 Million Growth rate CAGR of approximately 4.14% Base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Type, By Product, By Indication, By Application, By End-users, By Region By Type Intravascular Cooling Catheter, Intravascular Warming Catheter. By Product Consumables, Systems By Indication Acute myocardial infarction (AMI), Stroke, TBI, Cardiac Arrest, Fever/Infection, Other. By Application Operative Care, Acute/Critical Care, Preoperative Care, Post-operative Care Based on End-User: Surgical Centers, Emergency Care Units, Ambulatory Surgical Centers, Other By Region North America, Europe, Asia Pacific, LAMEA Country Scope United States of America, United Kingdom, Italy, Germany, France, Spain, Canada, China, India, Japan, Brazil, Argentina, Mexico, South Africa, Saudi Arabia, etc. Company Usability Profiles 3M company, Smiths Group Plc, ZOLL Medical, The 37Company, Belmont Instrument, Biegler, Stihler Electronic GmbH, BD company, Geratherm Medical AG, Stryker Corporation, The Surgical Company BV, VYAIRE MEDICAL INC. Recent Developments On June 2021, FDA announced the recall of multiple lots of Smiths Medical insulin syringes for the treatment of early cardiac arrest symptoms. For this, Smiths Medical has recalled 13 lots of its JELCO HYPODERMIC NEEDLE-PRO FIXED NEEDLE INSULIN SYRINGES for giving the cardiac patients proper early treatment and thus saving them from massive cardiac attacks. On January 2021, ZOLL Medical’s Advanced Defibrillators won a Five-Star rating for Safety & Health Asia Award 2020. These highly developed and advanced defibrillators doubled the cardiac arrest survival rates among patients across the globe and thus were regarded as one of the most efficient technologies ever discovered for cardiac arrest treatments. On April 2019, Stryker Corporation launched the LIFEPAK CR2 Defibrillator coupled with the LIFELINK central AED Program Manager in the U.S. The organization has announced that the LIFEPAK CR2 AED (automated external defibrillator) has received Premarket Approval (PMA) by FDA to save the patients from the higher rates of sudden cardiac arrests. Frequently Asked Question About This Report Who all are the key players in the global market? The leading industry players of the global market are Smiths Group Plc, ZOLL Medical, 3M company, Belmont Instrument, Biegler, Stihler Electronic GmbH, BD company, The 37Company, Geratherm Medical AG, Stryker Corporation, VYAIRE MEDICAL INC and The Surgical Company BV. How big is this intravascular temperature management market size ? The global intravascular temperature management market size was $279.23 Bn in 2021 and is predicted to reach $402.42 Bn by 2030, representing a CAGR of 4.14%. Which region dominates the global market? Based on Region, North America held the highest share of the market with a decent CAGR value throughout the stipulated time period of 2020-2030, followed by Europe. Which is the most dominant type of Product segment of the market? Based on Product, the Consumables segment accounted for the largest share of around 76.15% of the entire market in 2020. What are key factors that are fuelling the overall growth of the market? Key factors that are augmenting the overall growth of the market are an increase in cardiovascular diseases, the number of surgical procedures, and a rise in awareness for the usage of intravascular temperature devices. What is the Intravascular Temperature Management Market growth? The global intravascular temperature management market is expected to grow at a compound annual growth rate (CAGR) of 4.14% from 2021 to 2030 to reach USD 402.42 Billion by 2030. Sources https://www.who.int/health-topics/cardiovascular-diseases https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388795/ https://www.stryker.com/us/en/emergency-care/products/lifelink-central.html 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Intravascular Temperature Management Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Intravascular Temperature Management Market 4.2.1 Global Market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global Market, by Region, 2021 - 2030 (USD Million) 4.4 By Type Business Analysis 4.4.1 Global Market, By Type, 2021 - 2030 (USD Million) 4.5 By Product Business Analysis 4.5.1 Global Market, By Product Type, 2021 - 2030 (USD Million) 4.6 By Indication Business Analysis 4.6.1 Global Market, By Indication Type, 2021 - 2030 (USD Million) 4.7 By End-User Business Analysis 4.7.1 Global Market, By End-User Type, 2021 - 2030 (USD Million) 4.8 Application Business Analysis 4.8.1 Global Market, By Application, 2021 - 2030 (USD Million) 4.9 Value Chain Analysis 4.10 Market Variable Analysis 4.10.1 Market Drivers Analysis 4.10.2 Market Restraints Analysis 4.11 Business Environment Analysis Tool 4.11.1 Market PEST analysis 4.11.2 Market Porter’s analysis 4.12 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Product Analysis 5.11.1. Trends in Product (2014-2020) 5.11.2. Trends in Product (2021-2030) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Country) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Intravascular Temperature Management Manufacturing Sites, Area Served, Product Type 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Type Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Intravascular Cooling Catheter 7.3.1. Intravascular Cooling Catheter market, 2021 - 2030 (USD Million) 7.4. Intravascular Warming Catheter 7.4.1. Intravascular Warming Catheter market, 2021 - 2030 (USD Million) 8. Global Market: By Product Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Consumables 8.3.1. Consumables market, 2021 - 2030 (USD Million) 8.4. Systems 8.4.1. Systems market, 2021 - 2030 (USD Million) 9. Global Market: By Indication Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Acute myocardial infarction (AMI) 9.3.1. Acute myocardial infarction (AMI) market, 2021 - 2030 (USD Million) 9.4. Stroke 9.4.1. Stroke market, 2021 - 2030 (USD Million) 9.5. TBI (Traumatic Brain Injury) 9.5.1. TBI (Traumatic Brain Injury)market, 2021 - 2030 (USD Million) 9.6. Cardiac Arrest 9.6.1. Cardiac Arrest market, 2021 - 2030 (USD Million) 9.7. Fever/Infection 9.7.1. Fever/Infection market, 2021 - 2030 (USD Million) 9.8. Other 9.8.1. Other markets, 2021 - 2030 (USD Million) 10. Global Market: By End-User Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2021-2030) 10.3. Surgical Centers 10.3.1. Surgical Centers market, 2021 - 2030 (USD Million) 10.4. Emergency Care Units 10.4.1. Emergency Care Units market, 2021 - 2030 (USD Million) 10.5. Ambulatory Surgical Centers 10.5.1. Ambulatory Surgical Centers market, 2021 - 2030 (USD Million) 10.6. Other 10.6.1. Other markets, 2021 - 2030 (USD Million) 11. Global Market: By Application Segment Analysis 11.1. Introduction 11.2. Sales Volume & Revenue Analysis (2021-2030) 11.3. Preoperative Care 11.3.1. Preoperative Care market, 2021 - 2030 (USD Million) 11.4. Operative Care 11.4.1. Operative Care market, 2021 - 2030 (USD Million) 11.5. Post-operative Care 11.5.1. Post-operative Care market, 2021 - 2030 (USD Million) 11.6. Acute/Critical Care 11.6.1. Acute/Critical Care market, 2021 - 2030 (USD Million) 12. Global Market: Regional Outlook 12.1 North America 12.1.1. North America Market, By End-User Type, 2021 - 2030 (USD Million) 12.1.4. North America Market, By Application, 2021 - 2030 (USD Million) 12.1.5. North America Market, by Country, 2021 - 2030 (USD Million) 12.1.4.1. U.S. 12.1.4.1.1. U.S. Market, By End-User Type, 2021 - 2030 (USD Million) 12.1.4.2. Canada 12.1.4.2.1. Canada Market, By End-User Type, 2021 - 2030 (USD Million) 12.1.4.2.2. Canada Market, By Region, 2021 - 2030 (USD Million) 12.1.4.2.3. Canada Market, by Applications, 2021 - 2030 (USD Million) 12.2. Europe 12.2.1. Europe Market, By End-User Type, 2021 - 2030 (USD Million) 12.2.2. Europe Market, by By Application, 2021 - 2030 (USD Million) 12.2.5. Europe Market, by country, 2021 - 2030 (USD Million) 12.2.4.1 U.K. 12.2.4.1.1. U.K. Market, By End-User Type, 2021 - 2030 (USD Million) 12.2.4.1.2. U.K. Market, By Applications, 2021 - 2030 (USD Million) 12.2.4.1.3. U.K. Market, by Region, 2021 - 2030 (USD Million) 12.2.4.2. Germany 12.2.4.2.1. Germany Market, By End-User Type, 2021 - 2030 (USD Million) 12.2.4.2.2. Germany Market, By Application, 2021 - 2030 (USD Million) 12.2.4.2.3. Germany Market, by Region, 2021 - 2030 (USD Million) 12.2.4.3. France 12.2.4.3.1. France Market, By End-User Type, 2021 - 2030 (USD Million) 12.2.4.3.2. France Market, By Region, 2021 - 2030 (USD Million) 12.2.4.3.3. France Market, by Application, 2021 - 2030 (USD Million) 12.2.4.4. Rest of Europe 12.2.4.4.1. Rest of Europe Market, By End-User Type, 2021 - 2030 (USD Million) 12.2.4.4.2. Rest of Europe Market, By Region, 2021 - 2030 (USD Million) 12.2.4.4.3. Rest of Europe Market, by Application, 2021 - 2030 (USD Million) 12.3. Asia Pacific 12.3.1. Asia Pacific Market, By End-User Type, 2021 - 2030 (USD Million) 12.3.2. Asia Pacific Market, By Application, 2021 - 2030 (USD Million) 12.3.5. Asia Pacific Market, by country, 2021 - 2030 (USD Million) 12.3.4.1. China 12.3.4.1.1. China Market, By End-User Type, 2021 - 2030 (USD Million) 12.3.4.1.2. China Market, By Region, 2021 - 2030 (USD Million) 12.3.4.1.3. China Market, by Application, 2021 - 2030 (USD Million) 12.3.4.2. India 12.3.4.2.1. India Market, By End-User Type, 2021 - 2030 (USD Million) 12.3.4.2.2. India Market, By Region, 2021 - 2030 (USD Million) 12.3.4.2.3. India Market, by Application, 2021 - 2030 (USD Million) 12.3.4.3. Japan 12.3.4.3.1. Japan Market, By End-User Type, 2021 - 2030 (USD Million) 12.3.4.3.3. Japan Market, by Application, 2021 - 2030 (USD Million) 12.3.4.4. South Korea 12.3.4.4.1. South Korea Market, By End-User Type, 2021 - 2030 (USD Million) 12.3.4.4.3. South Korea Market, by Application, 2021 - 2030 (USD Million) 12.3.4.5. Rest of ASIA PACIFIC 12.3.4.5.1. Rest of ASIA PACIFIC Market, By End-User Type, 2021 - 2030 (USD Million) 12.3.4.5.3. Rest of ASIA PACIFIC Market, by Application, 2021 - 2030 (USD Million) 12.4. Latin America 12.4.1. Latin America Market, By End-User Type, 2021 - 2030 (USD Million) 12.4.3. Latin America Market, by Application, 2021 - 2030 (USD Million) 12.4.4. Latin America Market, by country, 2021 - 2030 (USD Million) 12.4.4.1. Brazil 12.4.4.1.1. Brazil Market, By End-User Type, 2021 - 2030 (USD Million) 12.4.4.1.3. Brazil Market, by Application, 2021 - 2030 (USD Million) 12.4.4.2. Mexico 12.4.4.2.1. Mexico Market, By End-User Type, 2021 - 2030 (USD Million) 12.4.4.2.3. Mexico Market, by Application, 2021 - 2030 (USD Million) 12.4.4.3. Rest of Latin America 12.4.4.3.1. Rest of the Latin America Market, By End-User Type, 2021 - 2030 (USD Million) 12.4.4.3.3. Rest of the Latin America Market, by Application, 2021 - 2030 (USD Million) 13. Competitive Landscape 13.1 3M company. 13.1.1. Company overview 13.1.2. Financial performance 13.1.3. Product Portfolio Analysis 13.1.4. Business Strategy & Recent Development 13.2. Smiths Group Plc. 13.2.1. Company overview 13.2.2. Financial performance 13.2.3. Product Portfolio Analysis 13.2.4. Business Strategy & Recent Development 13.3. ZOLL Medical. 13.3.1. Company overview 13.3.2. Financial performance 13.3.3. Product Portfolio Analysis 13.3.4. Business Strategy & Recent Development 13.4. The 37Company. 13.4.1. Company overview 13.4.2. Financial performance 13.4.3. Product Portfolio Analysis 13.4.4. Business Strategy & Recent Development 13.5. Belmont Instrument. 13.5.1. Company overview 13.5.2. Financial performance 13.5.3. Product Portfolio Analysis 13.5.4. Business Strategy & Recent Development 13.6. Biegler. 13.6.1. Company overview 13.6.2. Financial performance 13.6.3. Product Portfolio Analysis 13.6.4. Business Strategy & Recent Development 13.7. Stihler Electronic GmbH. 13.7.1. Company overview 13.7.2. Financial performance 13.7.3. Product Portfolio Analysis 13.7.4. Business Strategy & Recent Development 13.8. BD company. 13.8.1. Company overview 13.8.2. Financial performance 13.8.3. Product Portfolio Analysis 13.8.4. Business Strategy & Recent Development 13.9. Geratherm Medical AG. 13.9.1. Company overview 13.9.2. Financial performance 13.9.3. Product Portfolio Analysis 13.9.4. Business Strategy & Recent Development 13.10. Stryker Corporation. 13.10.1. Company overview 13.10.2. Financial performance 13.10.3. Product Portfolio Analysis 13.10.4. Business Strategy & Recent Development 13.11. The Surgical Company BV. 13.11.1. Company overview 13.11.2. Financial performance 13.11.3. Product Portfolio Analysis 13.11.4. Business Strategy & Recent Development 13.12. VYAIRE MEDICAL INC. 13.12.1. Company overview 13.12.2. Financial performance 13.12.3. Product Portfolio Analysis 13.12.4. Business Strategy & Recent Development List of Tables (61 Tables) TABLE 1. Market, By Type, 2021-2030 (USD Million) TABLE 2. Market FOR Intravascular Cooling Catheter, BY REGION, 2021-2030 (USD Million) TABLE 3. Market FOR Intravascular Warming Catheter, BY REGION, 2021-2030 (USD Million) TABLE 4. Market, By Product, 2021-2030 (USD Million) TABLE 5. Market FOR Consumables, BY REGION, 2021-2030 (USD Million) TABLE 6. Market FOR Systems, BY REGION, 2021-2030 (USD Million) TABLE 7. Market, By Indication Type, 2021-2030 (USD Million) TABLE 8. Market FOR Acute myocardial infarction (AMI), BY REGION, 2021-2030 (USD Million) TABLE 9. Market FOR Stroke, BY REGION, 2021-2030 (USD Million) TABLE 10. Market FOR TBI (Traumatic Brain Injury), BY REGION, 2021-2030 (USD Million) TABLE 11. Market FOR Cardiac Arrest, BY REGION, 2021-2030 (USD Million) TABLE 12. Market FOR Fever/Infection, BY REGION, 2021-2030 (USD Million) TABLE 13. Market FOR Other, BY REGION, 2021-2030 (USD Million) TABLE 14. Market, By End-User Type, 2021-2030 (USD Million) TABLE 15. Market FOR Surgical Centers, BY REGION, 2021-2030 (USD Million) TABLE 16. Market FOR Emergency Care Units, BY REGION, 2021-2030 (USD Million) TABLE 17. Market FOR Ambulatory Surgical Centers, BY REGION, 2021-2030 (USD Million) TABLE 18. Market FOR Other, BY REGION, 2021-2030 (USD Million) TABLE 19. Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 20. Market FOR Preoperative Care, BY REGION, 2021-2030 (USD Million) TABLE 21. Market FOR Operative Care, BY REGION, 2021-2030 (USD Million) TABLE 22. Market FOR Post-operative Care, BY REGION, 2021-2030 (USD Million) TABLE 23. Market FOR Acute/Critical Care, BY REGION, 2021-2030 (USD Million) TABLE 24. Market, BY REGION, 2021-2030 (USD Million) TABLE 25. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 26. NORTH AMERICA Market, BY Applications, 2021-2030 (USD Million) TABLE 27. NORTH AMERICA Market, By End-User Type, 2021-2030 (USD Million) TABLE 28. NORTH AMERICA Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 29. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 30. EUROPE Market, By End-User Type, 2021-2030 (USD Million) TABLE 31. EUROPE Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 32. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 33. ASIA-PACIFIC Market, By End-User Type, 2021-2030 (USD Million) TABLE 34. ASIA-PACIFIC Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 35. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 36. LAMEA Market, By End-User Type, 2021-2030 (USD Million) TABLE 37. LAMEA Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 38. 3M company: COMPANY SNAPSHOT TABLE 39. 3M company: OPERATING SEGMENTS TABLE 40. Smiths Group Plc: COMPANY SNAPSHOT TABLE 41. Smiths Group Plc: OPERATING SEGMENTS TABLE 42. ZOLL Medical: COMPANY SNAPSHOT TABLE 43. ZOLL Medical: OPERATING SEGMENTS TABLE 44. The 37Company: COMPANY SNAPSHOT TABLE 45. The 37Company: OPERATING SEGMENTS TABLE 46. Belmont Instrument: COMPANY SNAPSHOT TABLE 47. Belmont Instrument: OPERATING SEGMENTS TABLE 48. Biegler: COMPANY SNAPSHOT TABLE 49. Biegler: OPERATING SEGMENTS TABLE 50. Stihler Electronic GmbH: COMPANY SNAPSHOT TABLE 51. Stihler Electronic GmbH: OPERATING SEGMENTS TABLE 52. BD company: COMPANY SNAPSHOT TABLE 53. BD company: OPERATING SEGMENTS TABLE 54. Geratherm Medical AG: COMPANY SNAPSHOT TABLE 55. Geratherm Medical AG: OPERATING SEGMENTS TABLE56. Stryker Corporation: COMPANY SNAPSHOT TABLE 57. Stryker Corporation: OPERATING SEGMENTS TABLE 58. The Surgical Company BV: COMPANY SNAPSHOT TABLE 59. The Surgical Company BV: OPERATING SEGMENTS TABLE 60. VYAIRE MEDICAL INC: COMPANY SNAPSHOT TABLE 61. VYAIRE MEDICAL INC: OPERATING SEGMENTS List of Figures (26 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Application-Based Estimation Figure 6 Top 12 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Intravascular Temperature Management, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Intravascular Temperature Management, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By Type, 2019 vs 2025 (USD Million) Figure 12 Market, By Product, 2019 vs 2025 (USD Million) Figure 13 Market, By Indication, 2019 vs 2025 (USD Million) Figure 14 Market, By End-User, 2019 vs 2025 (USD Million) Figure 15 Market Share, By Application Type, 2019 vs 2025 Figure 16 Geographical Snapshot of the Market Figure 17 Intravascular Warming Catheter to Witness Higher CAGR in Market for Type Segment during Forecast Period. Figure 18 Consumables to Witness Higher CAGR in Market for Product Type Segment during Forecast Period. Figure 19 Cardiac Arrest to Witness Higher CAGR in Market for Indication Type Segment during Forecast Period. Figure 20 Surgical Centers to Witness Higher CAGR in Market for End-User Segment during Forecast Period. Figure 21 Acute/Critical Care to Witness Higher CAGR in Market for Application Segment during Forecast Period. Figure 22 Asia-Pacific Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 23 Market: Drivers, Restraints, Opportunities, and Challenges Figure 24 North America: Market Snapshot Figure 25 Asia Pacific: Market Snapshot Figure 26 Vendor Dive: Evaluation Overview